1. Stocks
    2. /
  2. Immutep Limited (ASX: IMM)
    3. /

Immutep Limited (ASX: IMM) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Immutep Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Immutep Limited (ASX: IMM)
    Latest News

    young female doctor with digital tablet looking confused.
    Healthcare Shares

    Immutep (ASX:IMM) share price slips amid trial safety update

    | Bernd Struben

    Initial study results look promising but investors don't appear too excited...

    Read more »

    share price dropping
    Share Market News

    Why Afterpay, Immutep, Pushpay, and Vulcan shares are falling

    | James Mickleboro

    These ASX shares are in the red today...

    Read more »

    A doctor in a white coat with a stethoscope around her neck holds her hands upwards as if to ask 'why' as she sits at her desk and looks at her computer.
    Healthcare Shares

    Immutep (ASX:IMM) share price slides 20% despite latest trial results

    | Zach Bristow

    The biotech company's shares are plunging despite positive news on its latest drug trial.

    Read more »

    Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
    Healthcare Shares

    Here's why the Immutep (ASX:IMM) share price is rising on Tuesday

    | Aaron Teboneras

    The company is expanding its intellectual property portfolio. We have the details

    Read more »

    man pointing up at a rising red line which represents a growing share price
    Healthcare Shares

    Immutep (ASX:IMM) share price hikes amid clinical trial momentum in FY21

    | Zach Bristow

    Here we unpack the biotech company's annual report to see where it made most progress in FY21.

    Read more »

    four excited doctors with their hands in the air
    Share Gainers

    The Immutep (ASX:IMM) share price is up 25% in a month and could go higher

    | James Mickleboro

    This biotech company's shares have been on fire...

    Read more »

    stock market gaining
    Share Gainers

    Why BlueBet, Dicker Data, Immutep, & Sandfire are charging higher

    | James Mickleboro

    These ASX shares are starting the month strongly...

    Read more »

    smiling health care workers in a medical setting
    Healthcare Shares

    Why the Immutep (ASX:IMM) share price is leaping 5% today

    | Brooke Cooper

    Immutep is one step closer to finishing its TACTI-002 trial.

    Read more »

    man jumping along increasing bar graph signifying jump in alumina share price
    Share Gainers

    Immutep (ASX:IMM) share price jumps 5% on Chinese patent grant

    | Zach Bristow

    Immutep shares make their walk northwards after a patent was granted on Friday.

    Read more »

    Rising healthcare ASX share price represented by doctor giving thumbs up
    Healthcare Shares

    Why the Immutep (ASX:IMM) share price is charging higher today

    | Bernd Struben

    Researchers are pursuing the silver bullet to defeat cancer.

    Read more »

    woman in lab coat conducting testing representing biotech
    Share Market News

    Capital keeps flowing into ASX Biotech shares in 2021

    | Zach Bristow

    What is driving capital inflow into ASX biotech shares?

    Read more »

    three excited doctors with hands in the air
    Healthcare Shares

    The 5 best performing ASX healthcare shares of FY21, did yours make the cut?

    | Mitchell Lawler

    These ASX shares had the healthiest gains in the last financial year...

    Read more »

    Frequently Asked Questions

    No, Immutep does not pay dividends at this time.

    Immutep Ltd listed on the ASX on 23 June 1988.

    IMM ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Immutep Limited

    Immutep Ltd (ASX: IMM) is a biotechnology company developing immunotherapy products for cancer and autoimmune diseases. The company describes itself as a pioneer in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system. Immutep's LAG-3 immunotherapies are designed to harness and strengthen the power of patients' immune systems to fight cancer and autoimmune diseases. Immutep currently has three clinical-stage candidates and two earlier-stage candidates.

    Profile

    since

    Note